Funding · Company
Human Longevity, Inc.
San Diego, CABiotech & Pharma
Human Longevity, Inc. of San Diego, CA has disclosed $32M across 1 Form D offering filed with the SEC on Aug 21, 2024.
$32M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$32M
Form D · Aug 21, 2024 ↗
Q3 2024
· 1 amendment, first filed Apr 7, 2023
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001781303Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →